Tyme Technologies

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

You can watch TYME and buy or sell other stocks, options, and ETFs commission-free!

About TYME

TYME Inc. is an emerging biotechnology company developing cancer therapeutics that are intended to be broadly effective across tumor types and have tolerable toxicity profiles. Unlike targeted therapies that attempt to regulate specific mutations within cancer, the Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic requirements to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s immune system. 

CEO
Richard Anthony Cunningham
CEORichard Anthony Cunningham
Employees
13
Employees13
Headquarters
Bedminster, New Jersey
HeadquartersBedminster, New Jersey
Founded
2011
Founded2011
Employees
13
Employees13

TYME Key Statistics

Market cap
53.50M
Market cap53.50M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.54M
Average volume1.54M
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$1.14
52 Week high$1.14
52 Week low
$0.2187
52 Week low$0.2187

TYME Earnings

-$0.05
-$0.03
-$0.02
$0.00
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Estimated
per share
Estimated per share
Actual
Expected Nov 8, Pre-Market
ActualExpected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.